Steroid 5α-Reductase Inhibitors
Journal:
Mini-Reviews in Medicinal Chemistry
Volume:
3
Page:
225-237
Author(s):
Eugenio Flores, Eugene Bratoeff, Marisa Cabeza, Elena Ramirez, Alexandra Quiroz and Ivonne Heuze
The BCL2-Family of Protein Ligands as Cancer Drugs: The Next Generation of Therapeutics
Journal:
Current Medicinal Chemistry - Anti-Cancer Agents
Volume:
3
Page:
217-223
Author(s):
WenJing Liu, Anca Bulgaru, Missak Haigentz, C. A. Stein, Roman Perez-Soler and Sridhar Mani
Peroxisome Proliferator Activated Receptor-Gamma Ligands as Potent Antineoplastic Agents
Journal:
Current Medicinal Chemistry - Anti-Cancer Agents
Volume:
3
Page:
239-251
Author(s):
S. Theocharis, A. Margeli and G. Kouraklis
Preface
Journal:
Current Drug Targets
Volume:
4
Page:
i-i
Author(s):
Martin Tenniswood
Tumor Cell Hypoxia and the Hypoxia-Response Signaling System as a Target for Prostate Cancer Therapy
Journal:
Current Drug Targets
Volume:
4
Page:
191-196
Author(s):
Aristotelis G. Anastasiadis, Debra L. Bemis, Brian C. Stisser, Laurent Salomon, Mohamed A. Ghafar and Ralph Buttyan
TGF-ß / Smad Signaling in Prostate Cancer
Journal:
Current Drug Targets
Volume:
4
Page:
197-207
Author(s):
Diana Bello-DeOcampo and Donald J. Tindall
Antisense Targets to Enhance Hormone and Cytotoxic Therapies in Advanced Prostate Cancer
Journal:
Current Drug Targets
Volume:
4
Page:
209-221
Author(s):
Martin Gleave, Colleen Nelson and Kim Chi
Par-4 for Molecular Therapy of Prostate Cancer
Journal:
Current Drug Targets
Volume:
4
Page:
223-230
Author(s):
James Butler and Vivek M. Rangnekar
Phytoestrogens and Prostate Cancer
Journal:
Current Drug Targets
Volume:
4
Page:
231-241
Author(s):
Colm Morrissey and R. William G. Watson
From TGF-β to Cancer Therapy
Journal:
Current Drug Targets
Volume:
4
Page:
243-250
Author(s):
Xuemei Huang and Chung Lee